Englewood Lab, Inc. (KOSDAQ:950140)

Market Cap	223.31B
Revenue (ttm)	204.62B
Net Income (ttm)	25.12B
Shares Out	19.87M
EPS (ttm)	1,263.90
PE Ratio	8.89
Forward PE	10.98
Dividend	100.00 (0.89%)
Ex-Dividend Date	Dec 27, 2024

Volume	77,261
Average Volume	107,386
Open	11,210
Previous Close	11,270
Day's Range	11,110 - 11,320
52-Week Range	6,410 - 16,910
Beta	0.48
RSI	35.56
Earnings Date	Feb 23, 2026

About Englewood Lab

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa, ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2004
• Country: United States
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950140

Financial Performance

In 2024, Englewood Lab's revenue was 182.22 billion, a decrease of -11.88% compared to the previous year's 206.78 billion. Earnings were 19.63 billion, a decrease of -5.37%.